Figure 1From: Treatment with gefitinib after erlotinib-induced liver injury: a case report Levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) during erlotinib therapy and subsequent gefitinib therapy in a 31-year-old Japanese woman with non-small cell lung cancer (NSCLC).Back to article page